The Week in Review: April 13 – April 20, 2018

Friday, April 20, 2018 News Recap: Green tea supplements may cause liver damage, warns EU watchdog. Green tea extracts may cause liver damage, the EU food safety watchdog today announced. Taking more than 800mg of green tea catechins each day may pose health concerns, according to the body's review. Officials were unable to confirm a safe dose. Race May Affect Ability to Achieve SVR in Hepatitis C.  After being treated with direct-acting antiviral...

Saskatchewan: Liver screening event looking for undiagnosed hepatitis cases

People lined up this morning at the La Ronge Health Centre to participate in a special liver screening.  The event was led by hepatitis C treatment support nurse Lesley Gallagher, who said the program is currently being rolled out in northern Saskatchewan. Aside from detecting hepatitis C, she said the two-day clinic acts as a point of care to get quick results in regards to other infectious diseases as well, because blood testing is also offered. Gallagh

The Week in Review: July 28 – August 4, 2017

Friday, August 4, 2017 Treatment: This last week saw the approval in the U.S. of AbbVie’s Mavyret, a pangenotypic also indicated as recuperation therapy for those with GT1 who have failed treatment with DAAs. U.S.: FDA approves Mavyret for Hepatitis C As well, the FDA has approved updated labeling for Epclusa to include use in patients co-infected with HIV. U.S. FDA Approves Expanded Labeling for Epclusa® (Sofosbuvir/Velpatasvir) for the Treatmen...

Sask. doctor concerned about ‘shockingly low’ number of hepatitis C patients being treated

This spring, the province expanded coverage for new drugs that have a 95% cure rate An infectious disease specialist in Regina is trying to raise awareness about the availability of drugs that have a 95 per cent cure rate for hepatitis C. Dr. Alex Wong, who works for the Regina Qu'Appelle Health Region, said to his knowledge there is no official number for how many people are living with the disease in Saskatchewan, but he estimates the number at anywh

The Week in Review: March 24, 2017 – March 31, 2017

Friday, March 31, 2017 News Recap Canada Good news from Saskatchewan this week: The Sask. Ministry of Health has signed a deal similar to those in BC, Ontario and Quebec and will soon be paying for six new drugs. The province estimates 12,000 people suffer from HepC in the province (Saskatchewan expands coverage for 6 hepatitis C drugs). Bad news from Calgary, Alberta: Alberta Health Services has shut down an illegal dental clinic in Calgary that...

Saskatchewan expands coverage for 6 hepatitis C drugs

Sask. Ministry of Health estimates 12,000 people suffer from blood-borne illness Saskatchewan will soon be paying for six new drugs targeted at people who suffer from hepatitis C. The drugs have a 95 per cent success rate and can cure patients in as little as eight to 12 weeks. "These new medications offer a much better chance of curing hepatitis C, and vastly improve patients' quality of life," said Health Minister Jim Reiter in a news release.

‘I thought my life was over’: World Hepatitis Day sparks awareness in Saskatoon

Saskatchewan has one of the highest rates of hepatitis C per capita in Canada World Hepatitis Day is on Thursday but residents in Saskatoon are looking to raise awareness all week. "I want people to know that they can get cured but they have to get tested," said hepatitis C survivor, Don Lesser. He was one of the participants at a testing fair for hepatitis C at the Friendship Inn on Tuesday. It was hosted by the Saskatchewan Infectious Disease Care N

Summer of Interferon-free Hepatitis C Drug Approvals?

2015 is stacking up to have a Summer of Interferon-Free hepatitis C drug approvals! So far we've had the following approvals for provincial Pharmacare coverage (addition to provincial "formulary"):On June 29th, Ontario covered AbbVie's Holkira Pak™ for genotype 1, on July 24th, Quebec covered both Gilead's Harvoni™ and AbbVie's Holkira Pak™ for genotype 1. And on World Hepatitis Day, July 28th British Columbia, Saskatchewan, Manitoba, and Yukon started to ...

Updated: HARVONI & SOVALDI now covered by BC PHARMACARE!!

HARVONI and SOVALDI ACCESS in CANADA, UPDATES as of March 26 (for original Press Release scroll to page bottom) British Columbia UPDATE on SOVALDI/HARVONI TREATMENT CRITERA and ACCESS as of March 26: BC PharmaCare Listing Criteria: BC PharmaCare Information for Prescribers – Sofosbuvir-ledipasvir (Harvoni™) for the treatment of chronic hepatitis C infection g

Simeprevir: two nods from Sask. & Health Canada

Simeprevir received two boosts on Nov. 12th: it is now listed on the Sasketchewan formulary (will be reimbursed by their public health insurance Pharmacare) and was also recommended highly by a Canadian Drug Review (CDR, CADTH, Health Canada) "Therapeutic Review" of hepatitis C DAA's (new Direct Acting Antiviral therapies) for HCV genotype 1. Details below: SASKATCHEWAN FORMULARY DETAILS: simeprevir, capsule, 150mg (Galexos-JAN) For the treatment of chroni